Peripheral neuropathies under Immune Checkpoint Inhibitors: A pharmacovigilance study

被引：0
|
作者：
Ewig, E. [1 ]
Fournier, D. [1 ]
Palassin, P. [2 ]
Cholle, C. [3 ]
Bihan, B. [1 ]
Lebrun-Vignes, B. [1 ]
机构：
[1] GH Sorbonne Univ, Dept Pharmacol, Ctr Reg Pharmacovigilance Pitie St Antoine, AP HP, Paris, France
[2] CHU Montpellier, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale & Toxicol, Montpellier, France
[3] CHU Bordeaux, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale, Pole Sante Publ, Bordeaux, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
immune checkpoint inhibitors; peripheral neuropathy; pharmacovigilance;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-043
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [21] Hematological toxicities in immune checkpoint inhibitors: A pharmacovigilance study from 2014 to 2019
    Ye, Xiaofei
    Hu, Fangyuan
    Zhai, Yinghong
    Qin, Yingyi
    Xu, Jinfang
    Guo, Xiaojing
    Zhuang, Yonglong
    He, Jia
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (04) : 565 - 575
  • [22] Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data
    Meunier, Lucy
    Hountondji, Lina
    Jantzem, Helene
    Faillie, Jean luc
    Maria, Alexandre
    Palassin, Pascale
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (07)
  • [23] Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review
    Nguyen, Lee S.
    Ortuno, Sofia
    Lebrun-Vignes, Benedicte
    Johnson, Douglas B.
    Moslehi, Javid J.
    Hertig, Alexandre
    Salem, Joe-Elie
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 36 - 47
  • [24] CANCER IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS IS ASSOCIATED WITH IMMUNE-MEDIATED REACTIONS: A PHARMACOVIGILANCE STUDY
    Ali, A. K.
    VALUE IN HEALTH, 2016, 19 (07) : A708 - A708
  • [25] DIAGNOSIS AND MANAGEMENT OF NEUROPATHIES RELATED TO IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES
    Cuzzubbo, S.
    Lozeron, P.
    Baroudjian, B.
    D'Oria, F.
    Tetu, P.
    Ursu, R.
    Gounant, V.
    Meppiel, E.
    Lambert, T.
    Tin, S. Ng Wing
    Duchemann, B.
    Belin, C.
    Lebbe, C.
    Carpentier, A. F.
    NEURO-ONCOLOGY, 2023, 25
  • [26] Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
    Nicoletti, Maria Maddalena
    Crisci, Erminia
    Cosenza, Vincenzo
    Riccardi, Consiglia
    Campitiello, Maria Rosaria
    Ruggiero, Donatella
    Berrino, Pasquale Maria
    Docimo, Giovanni
    Scavone, Cristina
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (01) : 33 - 41
  • [27] Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis
    Gu, Tianqi
    Jiang, Aimin
    Zhou, Chaozheng
    Lin, Anqi
    Cheng, Quan
    Liu, Zaoqu
    Zhang, Jian
    Luo, Peng
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (03) : 480 - 495
  • [28] Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
    Maria Maddalena Nicoletti
    Erminia Crisci
    Vincenzo Cosenza
    Consiglia Riccardi
    Maria Rosaria Campitiello
    Donatella Ruggiero
    Pasquale Maria Berrino
    Giovanni Docimo
    Cristina Scavone
    Drugs - Real World Outcomes, 2024, 11 : 33 - 41
  • [29] European Pharmacovigilance Analysis of Cardiac Arrhythmias Events with Immune Checkpoint Inhibitors
    Mascolo, A.
    Sportiello, L.
    Rafaniello, C.
    Scisciola, L.
    Barbieri, M.
    Rossi, F.
    Paolisso, G.
    Capuano, A.
    DRUG SAFETY, 2022, 45 (10) : 1115 - 1116
  • [30] Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
    Chen, Chenxin
    Chen, Ting
    Liang, Jizhou
    Guo, Xiaojing
    Xu, Jinfang
    Zheng, Yi
    Guo, Zhijian
    Chi, Lijie
    Wei, Lianhui
    Chen, Xiao
    Ye, Xiaofei
    He, Jia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345